+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Diasorin - logo

DiaSorin develops and manufactures reagents for in vitro diagnostics. It has products in the fields of infectious disease, hepatitis, endocrinology, bone and mineral metabolism, cancer, brain injury, cardiac, therapeutic drug monitoring, and autoimmunity. The company was formerly known as ImmunoNuclear Corporation. Operating through two dozen subsidiaries, DiaSorin has sales organizations in more than 60 countries.The company was founded in 1975 and is based in Stillwater, Minnesota. It operates as a subsidiary of DiaSorin S.p.A.

2021-2025 Europe Tumor Markers Business Opportunities - France, Germany, Italy, Spain, UK - Oncogenes, Bio Markers, GFs, CSFs, Hormones, Stains, Lymphokines - Product Thumbnail Image

2021-2025 Europe Tumor Markers Business Opportunities - France, Germany, Italy, Spain, UK - Oncogenes, Bio Markers, GFs, CSFs, Hormones, Stains, Lymphokines

  • Report
  • November 2021
  • Europe, United Kingdom, ... Europe, United Kingdom, Spain, Italy, Germany, France
From
From
From
Proteomics Market 2025-2029 - Product Thumbnail Image

Proteomics Market 2025-2029

  • Report
  • January 2025
  • 203 Pages
  • Global
From
Proteomics Market - Global Outlook and Forecast 2022-2027 - Product Thumbnail Image

Proteomics Market - Global Outlook and Forecast 2022-2027

  • Report
  • June 2022
  • 299 Pages
  • Global
From
From
Point of Care (POC) Diagnostics Market 2024-2028 - Product Thumbnail Image

Point of Care (POC) Diagnostics Market 2024-2028

  • Report
  • July 2024
  • 186 Pages
  • Global
From
Leukemia Screening - Global Strategic Business Report - Product Thumbnail Image

Leukemia Screening - Global Strategic Business Report

  • Report
  • June 2025
  • 487 Pages
  • Global
From
Loading Indicator